APDN: Second quarter revenue decline disappointing, but remain optimistic for long term growth
Applied DNA Sciences is a manufacturer of deoxyribonucleic acid (DNA) for supply chain security, brand protection, law enforcement or drug or biologic applications by using its polymerase chain reaction (PCR) based manufacturing platform. Under its wholly owned subsidiary, LineaRx, Inc., the company supplies DNA for use in the in vitro medical diagnostics, preclinical biotechnology and preclinical drug and biologic development and manufacturing markets. The company is also engaged in preclinical and animal drug candidate development directly and with collaborators focusing on therapeutically DNA constructs manufactured via its PCR-based DNA production platform.
Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.